SCHEMBL7950812

SCHEMBL7950812

CNNC(=O)CC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29039504 0.80 ALDH1A1 (0.41)
SCHEMBL23180523 0.78 KDM4E (0.46)
SCHEMBL97236 0.78
SCHEMBL5365359 0.77 ALDH1A1 (0.48)
SCHEMBL13650702 0.77 ALDH1A1 (0.42)
Hydrochloric Acid SCHEMBL11001835 0.76
SCHEMBL6633417 0.75 ALDH1A1 (0.40)
SCHEMBL20903255 0.75 KDM4E (0.43)
SCHEMBL6638050 0.75 CYP2D6 (0.41)
SCHEMBL5691924 0.75 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021252644-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-12-16 WO disclosed
US-20180030035-A1 AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY COMPOUND HANDLING B.V. (NL) 2018-02-01 US disclosed
US-9790205-B2 Aminomethylene pyrazolones with therapeutic activity COMPOUND HANDLING B.V. (NL) 2017-10-17 US disclosed
US-9790205-B2 Aminomethylene pyrazolones with therapeutic activity COMPOUND HANDLING B.V. (NL) 2017-10-17 US disclosed
US-20170240531-A1 AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY COMPOUND HANDLING B.V. (NL) 2017-08-24 US disclosed
US-20170240531-A1 AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY COMPOUND HANDLING B.V. (NL) 2017-08-24 US disclosed
US-9676764-B2 Aminomethylene pyrazolones with therapeutic activity COMPOUND HANDLING B.V. (NL) 2017-06-13 US disclosed
US-9676764-B2 Aminomethylene pyrazolones with therapeutic activity COMPOUND HANDLING B.V. (NL) 2017-06-13 US disclosed
US-20160326152-A1 AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY COMPOUND HANDLING B.V. (NL) 2016-11-10 US disclosed
US-20160326152-A1 AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY COMPOUND HANDLING B.V. (NL) 2016-11-10 US disclosed
US-9453012-B2 Aminomethylene pyrazolones with therapeutic activity COMPOUND HANDLING B.V. (NL) 2016-09-27 US disclosed
US-9453012-B2 Aminomethylene pyrazolones with therapeutic activity COMPOUND HANDLING B.V. (NL) 2016-09-27 US disclosed
US-20150073019-A1 AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY SPECS COMPOUND HANDLING B.V. (NL) 2015-03-12 US disclosed
US-20150073019-A1 AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY SPECS COMPOUND HANDLING B.V. (NL) 2015-03-12 US disclosed
WO-2009152458-A1 LIQUID FORMULATION SUITABLE FOR INFUSION COMPRISING AN ADENOSINE RECEPTOR ANTAGONIST FOR TREATING HEART FAILURE AND RENAL INSUFFICIENCY. BIOGEN IDEC MA INC. (US) 2009-12-17 WO disclosed